No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
GILD Gilead Sciences
- 89.880
- +0.740+0.83%
Close Jan 10 16:00 ET
- 89.500
- -0.380-0.42%
Post 19:56 ET
112.01BMarket Cap998.67P/E (TTM)
91.430High88.570Low7.87MVolume90.190Open89.140Pre Close705.67MTurnover0.63%Turnover Ratio19.97P/E (Static)1.25BShares98.07552wk High6.06P/B111.79BFloat Cap60.24352wk Low3.06Dividend TTM1.24BShs Float98.075Historical High3.40%Div YieldTTM3.21%Amplitude0.402Historical Low89.669Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
Gilead in Pact for Anti-inflammatory Drugs in a Deal Worth up to $1.7B
Bernstein Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $105
Express News | Gilead has reached a collaboration with Leo Pharma.
Express News | Gilead - Transaction With Leo Pharma Is Expected to Reduce Gilead’s Gaap and Non-Gaap 2025 EPS by Approximately $0.15 - $0.17
Express News | Gilead - Leo Pharma Is Eligible to Receive up to $1.7 Billion in Total Payments, Including an Upfront Payment of $250 Million
Trending US Stocks
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.
